Abaloparatide
Bone & mineral
A parathyroid hormone related peptide analogue with Phase 3 osteoporosis evidence for fewer new vertebral and nonvertebral fractures and increased bone mineral density in postmenopausal women.
An authorisation applies to at least one defined finished product in a stated jurisdiction; it does not apply automatically to this catalogue material.
What is Abaloparatide?
Abaloparatide is a synthetic parathyroid hormone related peptide analogue used in bone and mineral research, including studies of bone mineral density and fracture biology; the catalogue label denotes the research grade peptide.
Which research context has Abaloparatide been associated with?
Abaloparatide is associated with bone and mineral research as a synthetic parathyroid hormone related peptide analogue. In the Phase 3 ACTIVE trial in postmenopausal women with osteoporosis, the defined clinical product reduced new vertebral and nonvertebral fractures and increased bone mineral density versus placebo over 18 months. Authorisation and use depend on the formulation, population and jurisdiction, and this catalogue entry is not evidence of a finished authorised medicine.
What documentation is available for Abaloparatide?
Abaloparatide: Batch documents are not yet linked on this site. For this synthetic parathyroid hormone related peptide analogue expected evidence includes batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and sequence confirmation; analytical HPLC/UPLC chromatogram with method and purity criteria; peptide content, counterion and residual solvent/water declaration; and validated potency/assay for release. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for Abaloparatide?
Abaloparatide: Storage depends on the documented supplied presentation; as a synthetic parathyroid hormone related peptide analogue verify dry/lyophilised versus solution form, counterion and concentration, solvent or buffer composition, pH sensitivity, container closure compatibility and aggregation propensity which together determine stability. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.